Published in BMJ on November 22, 2003
Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One (2009) 3.45
Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ (2006) 3.02
A manifesto for clinical pharmacology from principles to practice. Br J Clin Pharmacol (2010) 2.94
Detection, verification, and quantification of adverse drug reactions. BMJ (2004) 2.26
Monitoring in chronic disease: a rational approach. BMJ (2005) 2.20
Communicating with patients about harms and risks. PLoS Med (2005) 2.03
Assessing the benefit-harm balance at the bedside. BMJ (2004) 1.77
Guest editorial. Health Expect (2005) 1.59
Developing drug prototypes: pharmacology replaces safety and tolerability? Nat Rev Drug Discov (2010) 1.58
Post-mortem clinical pharmacology. Br J Clin Pharmacol (2008) 1.48
Medication errors: problems and recommendations from a consensus meeting. Br J Clin Pharmacol (2009) 1.32
[Prevention of adverse drug reactions in older patients]. Z Gerontol Geriatr (2007) 1.27
Should we tolerate tolerability as an objective in early drug development? Br J Clin Pharmacol (2007) 1.14
Communicating information about drug safety. BMJ (2006) 1.08
Monitoring drug therapy. Br J Clin Pharmacol (2012) 1.02
Pharmacovigilance. Br J Clin Pharmacol (2012) 0.98
Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin. AAPS J (2005) 0.96
The NSAID roller coaster: more about rofecoxib. Br J Clin Pharmacol (2006) 0.92
Monitoring for adverse drug reactions. Br J Clin Pharmacol (2006) 0.91
The quality of information on monitoring for haematological adverse drug reactions. Br J Clin Pharmacol (2005) 0.89
Drug development: more science, more education. Br J Clin Pharmacol (2005) 0.87
Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff. Wien Klin Wochenschr (2010) 0.85
Adverse drug reactions--no farewell to harms. Br J Clin Pharmacol (2007) 0.85
Oculomotor nerve palsy associated with bortezomib in a patient with multiple myeloma: a case report. J Med Case Rep (2010) 0.84
Pattern of Adverse Drug Reactions in Children Attending the Department of Pediatrics in a Tertiary Care Center: A Prospective Observational Study. Clin Med Insights Pediatr (2015) 0.83
Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nat Commun (2015) 0.82
Drug-induced anaphylaxis: a decade review of reporting to the Portuguese Pharmacovigilance Authority. Eur J Clin Pharmacol (2012) 0.82
Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database. Drug Saf (2017) 0.78
Comparison of study designs used to detect and characterize pharmacogenomic interactions in nonexperimental studies: a simulation study. Pharmacogenet Genomics (2014) 0.78
Approaches to recording drug allergies in electronic health records: qualitative study. PLoS One (2014) 0.78
Laughter and MIRTH (Methodical Investigation of Risibility, Therapeutic and Harmful): narrative synthesis. BMJ (2013) 0.78
Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J (2015) 0.78
A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole. BMJ Case Rep (2014) 0.75
Antibiotics and allergic disorders in childhood. Open Nurs J (2008) 0.75
Adverse drug reactions. Br J Clin Pharmacol (2012) 0.75
Impact on Drug Safety of Variation in Adherence: The Need for Routinely Reporting Measures of Dose Intensity in Medication Safety Studies Using Electronic Health Data. Drug Saf (2015) 0.75
Characterization of Adverse Drug Reactions Causing Admission to an Intensive Care Unit. Br J Clin Pharmacol (2016) 0.75
An agenda for research on adverse drug reactions. Br J Clin Pharmacol (2007) 0.75
Monitoring for harms of therapy. Br J Clin Pharmacol (2006) 0.75
Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994. J R Coll Physicians Lond (1995) 4.55
Cephalosporin allergy. N Engl J Med (2001) 3.10
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Jaundice after repeated exposure to halothane: an analysis of Reports to the Committee on Safety of Medicines. Br Med J (1974) 2.56
Serious adverse events of mefloquine in relation to blood level and gender. Am J Trop Med Hyg (2001) 2.41
Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med (1987) 2.11
Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol (1983) 1.47
Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis (1991) 1.43
Interpreting atmospheric pollen counts for use in clinical allergy: allergic symptomology. Ann Allergy Asthma Immunol (2001) 1.38
Clinical pharmacology. Adverse reactions to drugs. Br Med J (Clin Res Ed) (1981) 1.35
Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs. Clin Pharmacol Ther (1981) 1.29
Chloramphenicol toxicity in neonates: its incidence and prevention. Br Med J (Clin Res Ed) (1983) 1.23
Chloramphenicol toxicity: 25 years of research. Am J Med (1989) 1.15
The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. Br J Clin Pharmacol (1990) 1.11
Normal immune response to hepatitis B vaccine in patients with Down's syndrome. A basis for immunization guidelines. JAMA (1985) 0.96
Natriuretic efficiency of frusemide as a consequence of drug input rate. Br J Clin Pharmacol (1997) 0.96
Adverse effects of the angiotensin-converting enzyme inhibitors. Ann Pharmacother (1996) 0.95
The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin. Br J Clin Pharmacol (1989) 0.93
The ampicillin rash as a diagnostic and management problem: case reports and literature review. J Fam Pract (1978) 0.90
Forbidden fruit. Nat Med (2001) 0.90
Methotrexate enterotoxicity: influence of drug dose and timing in the rat. Br J Cancer (1984) 0.89
Lithium clearance in patients with chronic renal diseases. Clin Nephrol (1991) 0.89
Newly licensed drugs. BMJ (1996) 6.68
Medical errors. Medical schools can teach safe drug prescribing and administration. BMJ (2001) 3.53
Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ (2006) 3.02
Is there a cure for drug errors? BMJ (1995) 2.55
Financial ties as part of informed consent to postmarketing research. Attitudes of American doctors and patients. BMJ (1995) 2.36
Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Lancet (1982) 2.30
Misleading drug packaging. BMJ (1995) 2.12
'The strategy of desire' and rational prescribing. Br J Clin Pharmacol (1994) 1.84
Minocycline for acne. BMJ (1996) 1.61
Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme. Br Med J (Clin Res Ed) (1987) 1.46
Why are thiazide diuretics declining in popularity? J Hum Hypertens (2001) 1.44
Lead poisoning from Asian traditional remedies in the West Midlands--report of a series of five cases. Hum Exp Toxicol (1995) 1.42
Alternative venlafaxine kinetics in overdose. J Clin Pharm Ther (2002) 1.40
Improving prescribing using a rule based prescribing system. Qual Saf Health Care (2004) 1.29
Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care (2010) 1.27
Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. J Clin Pharm Ther (2004) 1.23
Hazards, risks and reality. Br J Clin Pharmacol (1992) 1.20
Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology (2004) 1.17
Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2007) 1.14
Adverse drug reactions: who is to know? BMJ (1993) 1.13
Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol (2001) 1.09
Identification of novel deletion breakpoints bordered by segmental duplications in the NF1 locus using high resolution array-CGH. J Med Genet (2005) 1.06
Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. Br Med J (Clin Res Ed) (1983) 1.05
Comparative tolerability profiles of oral antidiabetic agents. Drug Saf (1994) 1.03
The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs. Clin Pharmacokinet (1987) 1.01
The influence of big pharma. BMJ (2005) 1.00
The safety of spironolactone treatment in patients with heart failure. J Clin Pharm Ther (2003) 0.99
The impact of PET scanning on management of paediatric oncology patients. Eur J Nucl Med Mol Imaging (2004) 0.99
Alcohol intake: measure for measure. BMJ (2001) 0.97
Testing the practical aspects of therapeutics by objective structured clinical examination. J Clin Pharm Ther (2004) 0.97
Poisoning with anti-hypertensive drugs: calcium antagonists. J Hum Hypertens (1995) 0.96
Systemic toxicity related to metal hip prostheses. Clin Toxicol (Phila) (2014) 0.92
Anabolic steroids: the power and the glory? BMJ (1988) 0.91
Monitoring for adverse drug reactions. Br J Clin Pharmacol (2006) 0.91
Atropine treatment for baclofen overdose. Postgrad Med J (1981) 0.90
Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1. Eye (Lond) (2011) 0.89
The lacing defence: double blind study of thresholds for detecting addition of ethanol to drinks. BMJ (2000) 0.89
Poisoning with anti-hypertensive drugs: angiotensin converting enzyme inhibitors. J Hum Hypertens (1995) 0.86
An analysis and comparison of commonly available United Kingdom prescribing resources. J Clin Pharm Ther (2010) 0.86
Laboratory monitoring and adverse patient outcomes with antihypertensive therapy in primary care. Pharmacoepidemiol Drug Saf (2010) 0.85
Plasma exchange for Guillain-Barré syndrome. J R Soc Med (1989) 0.85
Secondary prevention in coronary heart disease. Cost effectiveness of treatment must be borne in mind. BMJ (1998) 0.83
Paracetamol elimination in patients with non-insulin dependent diabetes mellitus. Br J Clin Pharmacol (1993) 0.83
Detailed analysis of the oligodendrocyte myelin glycoprotein gene in four patients with neurofibromatosis 1 and primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2000) 0.82
Multiple lower limb non-ossifying fibromas in siblings with neurofibromatosis. Eur J Radiol (1998) 0.81
Increase in US medication-error deaths. Lancet (1998) 0.80
Effects of short-term hyperglycemia on insulin secretion in normal humans. Am J Physiol (1986) 0.80
Should doctors who make clinical errors be charged with manslaughter? A survey of medical professionals and members of the public. Med Sci Law (2008) 0.78
Persistent insulin secretion after insulin overdose in a non-diabetic patient. Lancet (1993) 0.78
Rhabdomyolysis and acute renal failure following carbon monoxide poisoning: two case reports with muscle histopathology and enzyme activities. J Toxicol Clin Toxicol (1992) 0.78
The medico-legal significance of pharmacokinetic interactions with ethanol. Med Sci Law (2012) 0.77
Heparin-induced thrombosis. Postgrad Med J (1997) 0.77
Republished paper: Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Postgrad Med J (2010) 0.77
Decision support for sensible dosing in electronic prescribing systems. J Clin Pharm Ther (2011) 0.76
Episodes of environmental poisoning worldwide. Occup Environ Med (2002) 0.76
Our poisoned patients. QJM (2001) 0.76
Severe relapsing sulphonylurea-induced hypoglycaemia: a diagnostic and therapeutic challenge. Postgrad Med J (2003) 0.76
Chemical burns causing systemic toxicity. Arch Emerg Med (1993) 0.75
Adverse events in British hospitals. Retrospective case record analysis has been superseded. BMJ (2001) 0.75
Reducing medication errors. JAMA (2001) 0.75
Liver transplantation after paracetamol overdose. BMJ (1991) 0.75
A model for NICE in the US. BMJ (2009) 0.75
Lithium and pregnancy. Lancet (1992) 0.75
Overdose of diltiazem. BMJ (1994) 0.75
Are images mirages? J R Soc Med (1997) 0.75
The British Medical Journal and prescribing of minocycline for acne. Br J Dermatol (2013) 0.75
Pyrexia, anaemia and acute renal failure secondary to omeprazole. Postgrad Med J (1998) 0.75
Medication errors detected in infusions. Arch Intern Med (2003) 0.75
Lack of effect of co-trimoxazole on the pharmacokinetics and pharmacodynamics of nifedipine. Br J Clin Pharmacol (1990) 0.75
Drug advertising in medical journals. Lancet (2003) 0.75
Dispensing with prescriptions. BMJ (1994) 0.75
Why is there still disagreement over insulin secretion in non-insulin-dependent diabetes? Diabet Med (1986) 0.75
Safety of mianserin. Lancet (1988) 0.75
Outpatient preoperative assessment: the surgeon's view. Ann R Coll Surg Engl (1979) 0.75
Charcoal-column haemoperfusion does not significantly enhance chlormethiazole removal. Hum Toxicol (1986) 0.75
A radiographic lead in lead poisoning. Hum Exp Toxicol (1994) 0.75
A suitable case for treatment. Lancet (1995) 0.75
Acute renal failure without acute intravascular haemolysis after nomifensine overdosage. Hum Toxicol (1986) 0.75
Time to discontinue the use of solutions A and B as a cyanide 'antidote'. Occup Med (Lond) (1994) 0.75
Poisoning with anti-hypertensive drugs: beta-adrenoceptor blocker drugs. J Hum Hypertens (1995) 0.75
Poisoning with antihypertensive drugs: diuretics and potassium supplements. J Hum Hypertens (1995) 0.75
Acute non-oliguric renal failure secondary to sulphinpyrazone overdose. J Clin Pharm Ther (1992) 0.75
Pericardial effusion--an uncommon complication of Salmonella enteritis. Br J Clin Pract (1993) 0.75
Superficial hyperglycaemia. Lancet (1985) 0.75
Diuretic therapy for hypertension: a cancer risk? J Hum Hypertens (1999) 0.75
Fatal atheromatous embolization during coronary angiography. Cardiovasc Intervent Radiol (1982) 0.75
Monitoring of clozapine and norclozapine plasma concentration-time curves in acute overdose. J Toxicol Clin Toxicol (2000) 0.75
The metabolic effects of aspirin in fasting and fed subjects: relevance to the aetiology of Reye's syndrome. Eur J Clin Pharmacol (1990) 0.75
Acute interstitial nephritis after re-exposure to nomifensine. Hum Toxicol (1987) 0.75
Mirtazepine overdose and miosis. J Toxicol Clin Toxicol (2003) 0.75
Poisoning with anti-hypertensive drugs: methyldopa and clonidine. J Hum Hypertens (1995) 0.75
Angiotensin receptor antagonists--a new class of antihypertensive drug. J Clin Pharm Ther (1996) 0.75
Poisoning with anti-hypertensive drugs: alpha-adrenoceptor antagonists. J Hum Hypertens (1995) 0.75
Pleural effusion and fever in a middle-aged Asian man. Postgrad Med J (1999) 0.75
Tri-iodothyroacetic acid abuse in a female body builder. Lancet (1986) 0.75
Massive glibenclamide overdose without hypoglycaemia in a man with diabetes after partial pancreatectomy. Hum Toxicol (1986) 0.75
A focus on human toxicology. Hum Exp Toxicol (1993) 0.75
How should we react to adverse drug reactions? Postgrad Med J (2011) 0.75